Letter to the Editor
Superdiluted atropine at 0.01% reduces myopia progression in children and adolescents. A 5-year study of safety and effectiveness
La atropina superdiluida al 0,01% frena el aumento de miopía en niños-adolescentes. Un estudio a largo plazo 5 años de evolución: seguridad y eficacia
V.M. Asensio-Sánchez
Servicio de Oftalmología, Hospital Clínico Universitario, Valladolid, Spain
Read
23
Timeswas read the article
11
Total PDF
12
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2023 10 | 3 | 2 | 5 |
| 2023 6 | 1 | 0 | 1 |
| 2023 3 | 2 | 2 | 4 |
| 2022 8 | 1 | 2 | 3 |
| 2021 11 | 1 | 2 | 3 |
| 2021 6 | 1 | 2 | 3 |
| 2021 4 | 2 | 0 | 2 |
| 2020 9 | 0 | 1 | 1 |
| 2020 2 | 1 | 0 | 1 |
